# Oroboros Bio, Inc. — Form D

Oroboros Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-08. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-08-08
- Form: D
- Accession: 0001784807-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 6
- Date of first sale: 2019-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-346091

## Issuer

- Name: Oroboros Bio, Inc.
- CIK: 0001784807
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2 WARE STREET, NO. 405, CAMBRIDGE, MA, 02138
- Phone: 617-648-9100

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Sarah Silvergleid | Director | Cambridge, MA |
| Raffaella Squilloni | Director | Cambridge, MA |
| Robert Alexander Wesselhoeft IV | Director | Cambridge, MA |
| Sarah Silvergleid | Executive Officer | Cambridge, MA |
| Raffaella Squilloni | Executive Officer | Cambridge, MA |
| Robert Alexander Wesselhoeft IV | Executive Officer | Cambridge, MA |

## More

- [CIK 1784807 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1784807&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001784807-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.